(Press-News.org) New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients' risk of thrombosis when deciding for or against the use of preventive therapies for deep vein thrombosis (DVT) and venous thromboembolism (VTE). Specifically, the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, published in the February issue of the journal CHEST, focus on risk stratification of patients, suggesting clinicians should consider a patient's risk for DVT/VTE and risk for bleeding before administering or prescribing a prevention therapy.
"There has been a significant push in health care to administer DVT prevention for every patient, regardless of risk. As a result, many patients are receiving unnecessary therapies that provide little benefit and could have adverse effects," said Guidelines Panel Chair Gordon Guyatt, MD, FCCP, Department of Medicine, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada. "The decision to administer DVT prevention therapy should be based on the patients' risk and the benefits of prevention or treatment." To address this, the ACCP guidelines provide comprehensive risk stratification recommendations for most major clinical areas, including medical, nonorthopedic surgery, orthopedic surgery, pregnancy, cardiovascular disease, atrial fibrillation, stroke, pediatrics, and long-distance travel.
DVT/VTE RISK FACTORS FOR LONG-DISTANCE TRAVEL
Although developing a travel-related DVT/VTE is unlikely in most cases, the guidelines note that for long-distance flights, several factors may increase an individual's risk of developing a DVT/VTE, including previous DVT/VTE or known thrombophilic disorder; malignancy; recent surgery or trauma; immobility; estrogen use or pregnancy; and sitting in a window seat. For travelers with an increased risk for travel-related DVT/VTE, the guidelines recommend frequent ambulation, calf muscle stretching, sitting in an aisle seat if possible, or the use of below-knee graduated compression stockings. Conversely, the guidelines suggest there is no definitive evidence to support that dehydration, alcohol intake, or sitting in economy class increases a patient's risk for developing a DVT/VTE resulting from long-distance flights.
ASPIRIN AND NEW THERAPIES FOR DVT/VTE PREVENTION
The guidelines also provide recommendations related to the use of new or potential therapies for the prevention and treatment of DVT/VTE. Although aspirin is not a new therapy for the prevention of DVT/VTE, previous ACCP guidelines recommended against using aspirin as the single agent for prophylaxis in any surgical population. In the current edition, the ACCP has revised this recommendation and indicates aspirin is an option—although not typically the agent of choice—for the prevention of DVT/VTE in major orthopedic surgery.
"Although we are not recommending aspirin as the optimal DVT/VTE prophylaxis, we have reviewed the existing evidence and concluded that aspirin is an acceptable option in some instances where preventive therapy is needed," said guideline co-author Mark Crowther, MD, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. In regard to new oral anticoagulants, guideline authors recognize the recent clinical trials of apixaban and rivaroxaban, both direct factor Xa inhibitors, and dabigatran etexilate, a direct thrombin inhibitor, and offer recommendations for the new agents for select clinical conditions, including atrial fibrillation and orthopedic surgery.
INNOVATIONS IN ANTITHROMBOTIC GUIDELINES
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines include innovations that have significantly impacted the more than 600 recommendations for the prevention, diagnosis, and treatment of thrombosis. Two key advances are the more explicit and quantitative consideration of patient values and preferences and restriction of outcomes to only those deemed to be important for the patient. The latter innovation results in different interpretation of the body of evidence in thrombosis prevention that has previously focused on the detection of asymptomatic thrombosis by surveillance methods.
Guideline authors also took a more critical look at the overall process of guideline development, providing more methodologically sophisticated scrutiny of all available evidence. "The evidence review for the new guidelines was more rigorous than ever before, and our method for grading research studies has become even more stringent," said guideline co-author David Gutterman, MD, FCCP, ACCP Immediate Past President, Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin. "We believe that the objective rigorous application of the science of guideline development will ultimately best serve our patients."
The guidelines are endorsed by the following medical associations: the American Association for Clinical Chemistry, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, American Society of Hematology, International Society of Thrombosis and Hemostasis, and the American College of Obstetrics and Gynecology (pregnancy article only).
###For more information about the guidelines and accompanying clinician resources, visit http://www.chestnet.org and follow #AT9 on Twitter. Patient resources related to the guidelines are available through OneBreath, an initiative of The CHEST Foundation, the philanthropic arm of the ACCP.
ABOUT THE AMERICAN COLLEGE OF CHEST PHYSICIANS
The ACCP represents 18,400 members who provide patient care in the areas of pulmonary, critical care, and sleep medicine in the United States and more than 100 countries throughout the world. The mission of the ACCP is to promote the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. CHEST is the official peer-reviewed publication of the ACCP. More than 30,000 readers worldwide turn to CHEST in print and 400,000 people view CHEST online each month for the latest in chest-related medicine. For more information about the ACCP, visit www.chestnet.org or follow the ACCP via social media at http://www.facebook.com/accpchest and www.twitter.com @accpchest.
New guidelines suggest DVT prophylaxis not appropriate for all patients
2012-02-08
ELSE PRESS RELEASES FROM THIS DATE:
Brain mechanisms link foods to rising obesity rates
2012-02-08
CINCINNATI—An editorial authored by University of Cincinnati (UC) diabetes researchers to be published in the Feb. 7, 2012, issue of the journal Cell Metabolism sheds light on the biological factors contributing to rising rates of obesity and discusses strategies to reduce body weight.
According to the U.S. Centers for Disease Control, about one-third of U.S. adults are obese, a number that continues to climb.
"While we don't usually think of it this way, body weight is regulated. How much we weigh is influenced by a number of biological systems, and this is part ...
Metabolic profiles essential for personalizing cancer therapy
2012-02-08
One way to tackle a tumor is to take aim at the metabolic reactions that fuel their growth. But a report in the February Cell Metabolism, a Cell Press Publication, shows that one metabolism-targeted cancer therapy will not fit all. That means that metabolic profiling will be essential for defining each cancer and choosing the best treatment accordingly, the researchers say.
The evidence comes from studies in mice showing that tumors' metabolic profiles vary based on the genes underlying a particular cancer and on the tissue of origin.
"Cancer research is dominated now ...
Transmission of Clostridium difficile in hospitals may not be through contact with infected patients
2012-02-08
Contrary to current convention by which infection with the organism Clostridium difficile is regarded as an infection that is acquired by contact with symptomatic patients known to be infected with C. difficile, these may account for only a minority of new cases of the infection. These findings are important as they indicate that C. difficile infection, which can be fatal especially in older people, may not be effectively controlled by current hospital infection strategies.
In a study led by Professor Tim Peto of the John Radcliffe Hospital in Oxford, UK, and published ...
Mild cognitive impairment is associated with disability and neuropsychiatric symptoms
2012-02-08
In low- and middle-income countries, mild cognitive impairment—an intermediate state between normal signs of cognitive aging, such as becoming increasingly forgetful, and dementia, which may or may not progress—is consistently associated with higher disability and with neuropsychiatric symptoms but not with most socio-demographic factors, according to a large study published in this week's PLoS Medicine.
The established 10/66 Dementia Research Group interviewed approximately 15 000 people over 65 years of age who did not have dementia in eight low- and middle-incomes ...
Parcel2Go Hails UK's Entrepreneurial Spirit
2012-02-08
Online parcel delivery specialist Parcel2Go has applauded the drive and will to succeed of the thousands of people across the UK who decide to start their own businesses. In the face of rising unemployment across Britain and the threat of a double-dip recession, entrepreneurs of all kinds are grasping the opportunity to take control of their own future.
Figures released last month by the Office for National Statistics showed the number of people registered as self-employed in the UK increased by 101,000 during the three months to November 2011, representing a 3.5 per ...
More focus on men needed in HIV prevention
2012-02-08
Edward Mills of the University of Ottawa, Canada and colleagues argue in this week's PLoS Medicine that the HIV/AIDS response in Africa needs a more balanced approach to gender, so that both men and women are involved in HIV treatment and prevention. Traditionally, targeted efforts at reducing the impact of the HIV epidemic have focused on women and children while men have received considerably less attention.
The authors say: "The epidemiological evidence is accumulating, and indicates that males in sub-Saharan Africa are not accessing HIV services as often as their ...
Childhood Choice...Bank Account for Life?
2012-02-08
The average person in the UK has had their main bank account for more than 20 years, according to new research from Halifax.
In figures that demonstrate the average person's reluctance to move bank account providers, the bank found that:
- 1 in 10 adults still use the account that they opened between the ages of 1 and 15 years old as their main account today
- A third of adults opened their main current account between the ages of 16-24
- Over a quarter of people (26%) have held their current main account for more than 26 years
Parent and student account define ...
Administration of meningococcal vaccine with other routine infant vaccines appears effective
2012-02-08
CHICAGO – Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains and produced minimal interference with the response to the routine vaccinations, according to a study in the February 8 issue of JAMA.
Certain serogroup B Neisseria meningitidis (MenB) vaccines proved effective in clinical trials and controlled a clonal MenB outbreak in New Zealand; however, the high strain specificity of these vaccines ...
Risk of death from breast cancer higher among older patients
2012-02-08
CHICAGO – Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher risk of death from breast cancer, according to a study in the February 8 issue of JAMA.
"Breast cancer is the leading contributor to cancer incidence and cancer mortality in women worldwide, with 1,383,500 new cases in 2008. In the United States in 2008, 41 percent of these women were aged 65 years or older at diagnosis. Because breast cancer incidence increases with increasing age, changing demographics and continuously increasing life expectancy ...
Rotavirus vaccine not associated with increased risk of intestinal disorder in US infants
2012-02-08
CHICAGO – Although some data have suggested a possible increased risk of intussusception (when a portion of the small or large intestine slides forward into itself, like a telescope) after administration of the pentavalent rotavirus vaccine in infants, an analysis that included almost 800,000 doses administered to U.S. infants found no increased risk of this condition following vaccination, according to a study in the February 8 issue of JAMA.
"In 1999, the rhesus tetravalent rotavirus vaccine (RRV, Rotashield) was withdrawn from the U.S. market due to a significantly ...